Navigation Links
Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate
Date:3/23/2011

nts, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and most recent periodic reports on Form 10-Q and Form 8-K. Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business. Unless otherwise noted, Amgen is providing this information as of March 23, 2011 and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint vent
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
2. Study Demonstrates Relationship Between Subcutaneous IgG (SCIg) Dosage and Clinical Outcomes With Hizentra® Treatment in Patients With Primary Immunodeficiencies
3. AstraZeneca Initiates Phase III Clinical Programme Evaluating NKTR-118 for Treatment of Opioid-Induced Constipation
4. Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection
5. The Balance-Based Torso-Weighting® Treatment for Multiple Sclerosis Receives a NIH Recovery Act Grant
6. Los Angeles Dentist, Dr. Kevin Sands, Uses the Latest Technologies to Provide VIP Services and Treatments for His Patients
7. International Prostate Cancer Treatment Expert Dr. David B. Samadi Supports Kenyan Minister of Medical Services, Peter Anyang Nyongos Decision to Travel to the U.S. for Prostate Cancer Treatment
8. Practice Guidelines Confirm Utility of Endoscopic Radiofrequency Ablation (RFA) for the Treatment of Barretts Esophagus
9. Pew Applauds Introduction of Preservation of Antibiotics for Medical Treatment Act of 2011
10. Tris Announces NDA Acceptance of Extended Release Carbinoxamine Oral Suspension for the Treatment of Allergies in Kids Two Years and Older
11. Genus Oncology, LLC Announces Orphan Drug Status for GO-203-2c for Treatment of Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015  Excite Medical was established by its President, ... Excite Medical, under the leadership of Mr. Musallam ... a solid track record of providing unparalleled service and ... base.  Photo - http://photos.prnewswire.com/prnh/20150529/219412 ... been possible, in large part, due to Mr. ...
(Date:5/29/2015)... 2015 A six-hour certification program on "How ... the Cannabis World Congress & Business Exposition (CWCBExpo) ... .  Taking place on Wednesday, June 17 th ... at the leading event on the East Coast for the ... Clover Leaf University, the first cannabis university to be approved, ...
(Date:5/29/2015)... -- Eli Lilly and Company (NYSE: LLY ) ... Conference on Tuesday, June 9, 2015. Jeffrey Simmons ... will participate in a fireside chat at 2:20 p.m., ... webcast will be available on the "Webcasts & Presentations" ... A replay of the fireside chat will be available ...
Breaking Medicine Technology:Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4Lilly to Participate in Goldman Sachs Global Healthcare Conference 2
... Symmetry Medical Inc. (NYSE: SMA ), a ... industry and other medical markets, announced today that it will ... October 2, 2010 before the market opens on Thursday, November ... at 8:00 a.m. ET on Thursday, November 4, 2010. ...
... ARBOR, Mich., Oct. 14 The ... Secretary for Planning and Evaluation (ASPE) has selected ... that will enable researchers to perform comparative effectiveness ... (Logo: http://photos.prnewswire.com/prnh/20090507/NY12658LOGO ) ...
Cached Medicine Technology:Symmetry Medical to Report Third Quarter 2010 Financial Results on November 4, 2010 2Federal Government Selects Thomson Reuters to Build Tool That Streamlines Comparative Effectiveness Research 2
(Date:5/30/2015)... (PRWEB) May 30, 2015 Boston ... million in punitive and compensatory damages to a ... suffered serious complications following implantation of the company’s ... verdict rendered on May 28th in Delaware Superior ... compensatory damages after the jury found that the ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 At 73 years ... of vibrant health , which she attributes to a ... principles of good nutrition with the release of her new ... by Xlibris AU). , “Cook for Health and Longevity” features ... nutritious and mostly organic food . It is designed ...
(Date:5/30/2015)... May 30, 2015 Key Housing, a ... proud to announce their June 2015 featured apartment community: ... in San Francisco, Key Housing is helping those people ... what is one of the tightest apartment markets in ... posting, and understandably anyone who requires temporary San Francisco ...
(Date:5/30/2015)... Las Vegas, Nevada (PRWEB) May 30, 2015 ... effective treatment of acne scars, large pores, deep wrinkles, ... by a licensed medical professional, such as Dr. F. ... conducted some of the clinical trials in Las Vegas. ... and SmartScan technology into a system that delivers proven ...
(Date:5/29/2015)... Ready to hit the road? Before embarking on a ... their vehicles ready. With handicapped vehicles, there are even more ... is ready to help drivers get their handicapped vans ready ... , When planning for the big trip, drivers should be ... goes smoothly and they are prepared for all contingencies: ...
Breaking Medicine News(10 mins):Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 2Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 3Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 4Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 3Health News:San Francisco Corporate Housing Leader Key Housing Designates 388 Beale Street as Featured Community for June 2Health News:San Francisco Corporate Housing Leader Key Housing Designates 388 Beale Street as Featured Community for June 3Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 3Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3
... Sutter Health has announced,the appointment of Florence L. DiBenedetto ... new role January 5, 2009, succeeding longtime,General Counsel Gary ... Formerly senior partner of the Sacramento-based law ... past two decades, DiBenedetto,served for more than 10 years ...
... Progressive Lenses and Transitions® Lenses to Produce Optimal Visual Experience ... ... Two of the most distinguished names in the optical industry are ... ,Carl Zeiss Vision, a leader for 160 years in precision optics, ...
... HOLX ), a leading developer, manufacturer and supplier ... to serving the healthcare needs of women, today announced plans ... Monday, February 2, 2009 after market close. In conjunction with ... February 2, 2009 at 5:00 p.m. (eastern). , ...
... women who donated eggs to fertility clinics reported satisfaction ... physical symptoms and 20 percent reported lasting psychological effects, ... effects of donation. , The research by scientists at ... at clinics in 20 states and is the largest ...
... Million Prescriptions , , BETHESDA, ... owned subsidiary of the Cystic Fibrosis Foundation, today announced its ... fibrosis (CF) community nationwide. , , ... one prescription and a mission to improve access to specialty ...
... Joint Commission Compliance through Patient Engagement , ... an effort to improve patient safety and standards compliance, ... (IPC) solutions, is enabling King,s Daughters Medical Center (KDMC) to ... Goal (NPSG) 16 through GetWellNetwork,s interactive PatientLife System(R) . ...
Cached Medicine News:Health News:Sutter Health Welcomes New General Counsel 2Health News:Carl Zeiss Vision and Transitions Optical Inc. Promote Pioneering Eyewear to Consumers 2Health News:Hologic, Inc. to Release First Quarter Fiscal 2009 Operating Results on Monday, February 2, 2009 2Health News:Most women report satisfaction with egg donation; some claim problems 2Health News:Most women report satisfaction with egg donation; some claim problems 3Health News:Cystic Fibrosis Services Pharmacy Celebrates 20th Anniversary 2Health News:King's Daughters Medical Center Leverages Unique Bedside Interactive Technology to Meet Requirements of Patient Safety Goal 16 2Health News:King's Daughters Medical Center Leverages Unique Bedside Interactive Technology to Meet Requirements of Patient Safety Goal 16 3
... The Vibratome 1000 Sectioning System provides ... fixed, animal, or plant tissues. The ... allows sectioning without freezing or embedding. ... morphology, the destruction of enzyme activities, and ...
... 1500 Sectioning System provides a versatile means ... plant tissues. The 1500 employs a ... freezing or embedding. The creation of ... of enzyme activities, and other deleterious effect ...
... System provides a versatile means of sectioning ... The 1000 employs a vibrating blade ... embedding. The creation of artifacts, the ... activities, and other deleterious effects inherent in ...
... provides a versatile means of sectioning fresh ... The 1500 employs a vibrating blade principle ... The creation of artifacts, the alteration ... and other deleterious effect inherent in freezing ...
Medicine Products: